Showing BioInteractions for Myrrh (DB11605)
BioInteractor utilizes data on drug-target, -enzyme and -transporter associations to provide insight on drug-drug interactions. It allows you to identify, for instance, which drugs act similarly on the same target. Such drugs may have additive pharmacodynamic effects if given concomitantly. Conversely, two drugs may antagonize the beneficial effects of each other by having opposite actions on a specific drug target. BioInteractor uses ranked drug-enzyme association information to predict enzyme-mediated drug interactions that may be clinically relevant.
Interacting Group | Interacting Drugs | |
---|---|---|
Myrrh is a Bile acid receptor antagonist | ||
1 | Bile acid receptor agonists | alpha-Linolenic acid, Farnesol, Obeticholic acid |
2 | Bile acid receptor ligands | Arachidonic Acid |
Interacting Group | Interacting Drugs | |
---|---|---|
Myrrh is a Nuclear receptor subfamily 1 group I member 2 partial agonist | ||
1 | Nuclear receptor subfamily 1 group I member 2 binders | Docetaxel, Estradiol |
2 | Nuclear receptor subfamily 1 group I member 2 agonists | Dexamethasone, Dexamethasone acetate, Erlotinib, Ethinylestradiol, Nifedipine, Rifampicin, Rifaximin, Rilpivirine |
3 | Nuclear receptor subfamily 1 group I member 2 inducers | Paclitaxel |
4 | Nuclear receptor subfamily 1 group I member 2 activators | Carbamazepine, Clotrimazole, Ethotoin, Mephenytoin, Methylphenobarbital, Pentobarbital, Phenobarbital, Prasterone, Quercetin, Ritonavir, Sulfinpyrazone, Troleandomycin |
5 | Nuclear receptor subfamily 1 group I member 2 partial agonists | Bezafibrate, Clonazepam, Econazole, Fenofibrate, Fenofibric acid, Miconazole, Oxiconazole |
6 | Nuclear receptor subfamily 1 group I member 2 antagonists | Ketoconazole |
7 | Nuclear receptor subfamily 1 group I member 2 suppressors | Dovitinib |
Interacting Group | Interacting Drugs | |
---|---|---|
Myrrh is a Peroxisome proliferator-activated receptor alpha agonist | ||
1 | Peroxisome proliferator-activated receptor alpha agonists | Aleglitazar, Amiodarone, Bezafibrate, Cardarine, Clofibrate, Fenofibrate, Fenofibric acid, Gemfibrozil, Indomethacin, Isoflavone |
2 | Peroxisome proliferator-activated receptor alpha activators | Fenoprofen, Flufenamic acid, Ibuprofen, Leukotriene B4, Omega-3 fatty acids, Prasterone, Soybean oil |
3 | Peroxisome proliferator-activated receptor alpha ligands | Doconexent |
Interacting Group | Interacting Drugs | |
---|---|---|
Myrrh is a Cytochrome P450 3A Subfamily inducer | ||
1 | Cytochrome P450 3A Subfamily inhibitors | Crizotinib, Diacerein, Fluvoxamine, Glecaprevir, Istradefylline, Lemborexant, Lonafarnib, Lopinavir, Lorlatinib, Midostaurin, Nefazodone, Olanzapine, Phenelzine, Pibrentasvir, Remoxipride, Rhein, Risdiplam, Selpercatinib |
2 | Cytochrome P450 3A Subfamily substrates | Acalabrutinib, Ambroxol acefyllinate, Budesonide, Dolutegravir, Elagolix, Ethosuximide, Foretinib, Glecaprevir, Lonafarnib, Lorlatinib, Loxoprofen, Mebendazole, Methylprednisolone, Midostaurin, Mirodenafil, Moxisylyte, Naldemedine, Omega-3-carboxylic acids, Relugolix, Tazemetostat, Thiopental, Tucatinib, Zanubrutinib |
3 | Cytochrome P450 3A Subfamily inducers | Brigatinib, Budesonide, Lemborexant, Methylprednisolone, Midostaurin, Prednisolone phosphate, Prednisone, Relugolix, Rifapentine |